The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to late-breaking research presented today in a Hot Line Late-breaking Clinical Trial session at he European Society of Cardiology (ESC) Congress. The results of the The Left Atrial Appendage Closure by Surgery (LAACS) study suggest that LAA closure should be routinely added to open heart surgery.
Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research from the DETO2X-AMI Study presented in a Hot Line session at the European Society of Cardiology (ESC) Congress and published in the New England Journal of Medicine (NEJM).
PURE study may cause revision of fat intake guidelines for cardiology.

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of global dietary guidelines in light of new late-breaking data presented from the Prospective Urban-Rural Epidemiology (PURE) on fat intake and cardiovascular risk and mortality. The study was presented at ESC and also published in the Lancet.

In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U.S. Food and Drug Administration (FDA)-cleared high sensitive Elecsys Troponin T Gen 5 blood test (Troponin T Gen 5 or TnT Gen 5) to aid in the diagnosis of heart attacks.  The new nine-minute test offers faster answers clinicians can use when diagnosing heart attack.

Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain.

Echo for the Sonographer and Practitioner: Point-of-Care Ultrasound and Advanced Echo Tract

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

Basic to Advanced Echo

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

 

Echo Workshop at Vail

This is a Mayo Clinic CME course. For more information on Mayo cardiac courses go to https://cveducation.mayo.edu/store/

 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now